Covered recipient · General Payments record
LIANA POGHOSYAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,114.69
- Reported across 75 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $743.43 | 26 |
| Education | $32.27 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $251.30 | 6 |
| Amgen Inc. | $145.16 | 7 |
| Ardelyx, Inc. | $144.45 | 5 |
| ABBVIE INC. | $59.83 | 2 |
| Esperion Therapeutics, Inc. | $42.56 | 2 |
| AIMMUNE THERAPEUTICS, INC. | $30.63 | 1 |
| SHIELD THERAPEUTICS INC | $30.00 | 1 |
| SANOFI-AVENTIS U.S. LLC | $26.85 | 1 |
| Lilly USA, LLC | $23.08 | 1 |
| Acerta Pharma LLC | $21.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.81 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105283236 | CMS |
| ABBVIE INC. | $25.02 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105283240 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $30.63 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146977374 | CMS |
| Amgen Inc. | $22.86 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117355199 | CMS |
| Amgen Inc. | $31.61 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111678149 | CMS |
| Amgen Inc. | $18.69 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117355201 | CMS |
| Amgen Inc. | $4.38 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117355205 | CMS |
| Amgen Inc. | $18.18 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117355203 | CMS |
| Amgen Inc. | $20.24 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117355207 | CMS |
| Amgen Inc. | $29.20 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111678147 | CMS |
| Ardelyx, Inc. | $26.90 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146701294 | CMS |
| Ardelyx, Inc. | $44.11 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146701296 | CMS |
| Ardelyx, Inc. | $6.85 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146701298 | CMS |
| Ardelyx, Inc. | $31.78 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146701300 | CMS |
| Ardelyx, Inc. | $34.81 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146701302 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.84 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105728999 | CMS |
| Esperion Therapeutics, Inc. | $19.78 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129451008 | CMS |
| Esperion Therapeutics, Inc. | $22.78 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129451010 | CMS |
| Lilly USA, LLC | $23.08 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135089673 | CMS |
| Novo Nordisk Inc | $32.27 | 01/18/2024 | Education | Undisputed | 01/23/2026 | 1097534007 | CMS |
| Novo Nordisk Inc | $97.16 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097456355 | CMS |
| Novo Nordisk Inc | $48.76 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096901987 | CMS |
| Novo Nordisk Inc | $26.53 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097279412 | CMS |
| Novo Nordisk Inc | $22.33 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097097085 | CMS |
| Novo Nordisk Inc | $24.25 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097218787 | CMS |
| SANOFI-AVENTIS U.S. LLC | $26.85 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139802618 | CMS |
| SHIELD THERAPEUTICS INC | $30.00 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150147399 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.